Johns Hopkins HIV Guide
Vancomycin
INDICATIONS
FDA
FDA
- Treatment of serious or severe infections caused by susceptible strains of MRSA
- Initial therapy when MRSA is suspected
- Oral vancomycin: antibiotic-associated pseudomembranous colitis caused by C. difficile and enterocolitis caused by S. aureus (including MRSA)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Bone and joint infections, including hardware-associated infections
- Pneumonia
- Septicemia
- Endocarditis due to Gram-positive organisms
- Skin and skin structure infections
- Meningitis, CNS shunt infections
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 14, 2024
Citation
Soto, Caitlin, and Kathryn Dzintars. "Vancomycin." Johns Hopkins HIV Guide, The Johns Hopkins University, 2024. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545217/all/Vancomycin.
Soto C, Dzintars K. Vancomycin. Johns Hopkins HIV Guide. The Johns Hopkins University; 2024. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545217/all/Vancomycin. Accessed September 27, 2025.
Soto, C., & Dzintars, K. (2024). Vancomycin. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545217/all/Vancomycin
Soto C, Dzintars K. Vancomycin [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2024. [cited 2025 September 27]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545217/all/Vancomycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vancomycin
ID - 545217
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Dzintars,Kathryn, Pharm.D., BCPS
Y1 - 2024/04/14/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545217/all/Vancomycin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
